These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30446441)

  • 1. Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
    Martini T; Heinkele J; Mayr R; Weis CA; Wezel F; Wahby S; Eckstein M; Schnöller T; Breyer J; Wirtz R; Ritter M; Bolenz C; Erben P
    Urol Oncol; 2018 Dec; 36(12):530.e19-530.e27. PubMed ID: 30446441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
    von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
    Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
    Fritsche HM; May M; Denzinger S; Otto W; Siegert S; Giedl C; Giedl J; Eder F; Agaimy A; Novotny V; Wirth M; Stief C; Brookman-May S; Hofstädter F; Gierth M; Aziz A; Kocot A; Riedmiller H; Bastian PJ; Toma M; Wieland WF; Hartmann A; Burger M
    Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
    Li Z; Wang KE; Zhou XL; Zhou J; Ye CH
    Med Sci Monit; 2018 Jan; 24():438-447. PubMed ID: 29358570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
    Otto W; May M; Fritsche HM; Dragun D; Aziz A; Gierth M; Trojan L; Herrmann E; Moritz R; Ellinger J; Tilki D; Buchner A; Höfner T; Brookman-May S; Nuhn P; Gilfrich C; Roigas J; Zacharias M; Denzinger S; Hohenfellner M; Haferkamp A; Müller SC; Kocot A; Riedmiller H; Wieland WF; Stief CG; Bastian PJ; Burger M
    Gend Med; 2012 Dec; 9(6):481-9. PubMed ID: 23217567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.
    Spradling K; Lotan Y; Shokeir A; Abol-Enein H; Mosbah A; Morgan JB; Ghoneim M; Youssef RF
    Urol Oncol; 2016 Sep; 34(9):417.e1-8. PubMed ID: 27157247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
    Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
    Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V
    World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.